Khurana Ankit, Dhankhar Vaneet, Goel Navneet, Gupta Rishi, Goyal Ashish
Department of Orthopaedics, Dr BSA Medical College and Hospital, Delhi, India.
Department of Biostatistics, Manokalp Clinic, Delhi, India.
J Clin Orthop Trauma. 2020 Sep 6;13:9-14. doi: 10.1016/j.jcot.2020.09.002. eCollection 2021 Feb.
Plantar fasciitis, which is a common cause of heel pain, often results in significant morbidity. In cases who are not responsive to initial conservative treatment, invasive procedures, often in the form of local infiltration of steroid are required. These procedures are associated with significant complications. Local Platelet Rich Plasma (PRP) infiltration is an emerging addition to these treatments. However, whether it is more effective in reducing pain and improving function than other treatments (such as steroid injections or whole blood) remains controversial.
Skeletally mature patients with plantar fasciitis who had failed conservative therapy were randomized using envelope method into 2 groups: PRP and Steroid group. The participants were assessed for pain using Visual Analog Scale on the day of presentation, and then after therapy at 2 weeks, 4 weeks, 3 months, and 6 months. They were additionally assessed on final follow-up using AOFAS hind-foot Score.
118 patients were randomized into 2 groups: 58 patients to the PRP group and 60 to the Steroid group. PRP was associated with greater improvement in VAS score and resulted in superior AOFAS score at 6 months as compared to steroid injection. The authors did not find any local or systemic complications in any of the groups. The result and difference were more pronounced as the time from injection increased and maximal benefit was observed at 6 months follow-up. None of the patients needed a repeat injection at 6 months.
Our study expands on the previous studies to provide a better evidence for superiority of PRP over local injection of steroid in plantar fasciitis, and the authors conclude that PRP provides better pain relief and function as compared to steroid injection.
Level 1 Prospective Randomized Control Trial (RCT).
足底筋膜炎是足跟痛的常见原因,常导致明显的发病率。对于初始保守治疗无反应的病例,需要采用侵入性治疗方法,通常是局部注射类固醇。这些治疗方法会引发严重的并发症。局部富血小板血浆(PRP)注射是这些治疗方法中的一种新兴补充手段。然而,与其他治疗方法(如类固醇注射或全血注射)相比,其在减轻疼痛和改善功能方面是否更有效仍存在争议。
采用信封法将保守治疗失败的足底筋膜炎骨骼成熟患者随机分为两组:PRP组和类固醇组。在就诊当天、治疗后2周、4周、3个月和6个月,使用视觉模拟量表对参与者的疼痛进行评估。在最终随访时,使用美国足踝外科协会(AOFAS)后足评分对他们进行额外评估。
118例患者被随机分为两组:58例患者进入PRP组,60例进入类固醇组。与类固醇注射相比,PRP组在VAS评分上有更大改善,在6个月时AOFAS评分更高。作者在任何一组中均未发现任何局部或全身并发症。随着注射后时间的增加,结果和差异更加明显,在6个月随访时观察到最大益处。6个月时,没有患者需要重复注射。
我们的研究在先前研究的基础上进行了扩展,为PRP在足底筋膜炎治疗中优于局部注射类固醇提供了更好的证据,作者得出结论,与类固醇注射相比,PRP能提供更好的疼痛缓解和功能改善。
1级前瞻性随机对照试验(RCT)。